Small molecule inhibitors of grp78 and uses thereof
AssigneeThe Regents of the University of Michigan
InventorsNouri Neamati, Joyeeta Roy, Soma Samanta, Suhui Yang, Ding Xue
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Regents of the University of Michigan
InventorsNouri Neamati, Joyeeta Roy, Soma Samanta, Suhui Yang, Ding Xue
Estimating the term…
This invention is in the field of medicinal chemistry. In particular, the invention relates to a new class of small-molecules as defined within Formula I (as defined herein) which function as inhibitors of glucose-regulated protein 78 (GRP78) within cancer cells and/or immune cells, and which function as effective therapeutic agents for treating, ameliorating, and preventing various forms of cancer (e.g., pancreatic cancer), viral infections (e.g. SARS-CoV-2), and inflammatory diseases. In addition, this invention also relates to a new class of PROTACs having Formulas II, III and IV (as defined herein) which function as degraders of GRP78 within cancer and/or immune cells. Pharmaceutical compositions comprising said compounds of Formulas I, II, III, or IV are also within the scope of the present invention.
A compound described by Formula I:
A compound described by Formula I:
A compound described by Formula Ib:
A compound described by Formula II:
A compound described by Formula III:
A compound described by Formula IV:
A compound selected from one of the compounds recited in Tables I or II.
Dependencies are inferred from the claim text.